Sandoz Group AG (MEX:SDZN) Notes Receivable: MXN0 Mil (As of Dec. 2025)


MEX:SDZN Sandoz Group AG MEX:SDZN
16 GF Score
Price MXN1,481.70
! 6 Warning Signs
View Full Analysis

What is Sandoz Group AG Notes Receivable?

Sandoz Group AG MEX:SDZN 16 Notes Receivable is MXN0 Mil as of Dec. 2025. GuruFocus rates MEX:SDZN with a GF Score™ of 16/100. The stock has 6 warning signs investors should review.

Sandoz Group AG's Notes Receivable for the quarter that ended in Dec. 2025 was MXN0 Mil.

Sandoz Group AG Notes Receivable Related Terms

Sandoz Group AG Notes Receivable Historical Data

* Premium members only.

The historical data trend for Sandoz Group AG's Notes Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sandoz Group AG Notes Receivable Chart

Sandoz Group AG Annual Data
Trend Dec22 Dec23 Dec24 Dec25
Notes Receivable
0.00 0.00 0.00 0.00

Sandoz Group AG Semi-Annual Data
Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Notes Receivable Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00
MEX:SDZN
16GF Score
Sandoz Group AG MEX:SDZN
Notes Receivable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sandoz Group AG Notes Receivable Calculation

Notes Receivable is an unconditional promise to receive a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer.

Frequently Asked Questions Learn more about Notes Receivable →
What does a Notes Receivable of MXN0 Mil mean?
Sandoz Group AG (MEX:SDZN) has a Notes Receivable of MXN0 Mil as of Dec. 2025. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on Sandoz Group AG and its competitors.
Is Sandoz Group AG's Notes Receivable too high?
Sandoz Group AG's current Notes Receivable is MXN0 Mil. Overall, Sandoz Group AG has a GF Score™ of 16/100, reflecting its overall financial health beyond just this single metric.
How does Sandoz Group AG's Notes Receivable compare to ZTS and UTHR?
Sandoz Group AG's Notes Receivable of MXN0 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Notes Receivable for a Drug Manufacturers company?
A good Notes Receivable depends on the Drug Manufacturers industry context. However, Notes Receivable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Notes Receivable mean?
A high Notes Receivable can signal that a stock is expensive relative to its fundamentals. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on Sandoz Group AG and its competitors. Sandoz Group AG's current Notes Receivable is MXN0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sandoz Group AG stock overvalued right now?
Sandoz Group AG (MEX:SDZN) has a current Notes Receivable of MXN0 Mil. The current Notes Receivable is MXN0 Mil. Sandoz Group AG's overall GF Score™ is 16/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Notes Receivable calculated?
Notes Receivable is calculated from a company's financial statements. For Sandoz Group AG (MEX:SDZN), the current Notes Receivable is MXN0 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Sandoz Group AG Business Description

Address Centralbahnstrasse 4, Basel, CHE, 4051
Sandoz is one of the largest generic pharmaceutical manufacturers in the world, generating over $11 billion annually from off-patent drugs. Once part of Novartis, Sandoz spun off and went public in October 2023. Generics, including small molecules and complex injectables, make up roughly 75% of Sandoz's total sales, and the firm has a significant presence in Europe, the United States, and other key international markets. Sandoz generates its remaining sales from biosimilars and is among the leaders in the space. Sandoz launched Europe's first biosimilar, Omnitrope, in 2006, as well as the first US biosimilar, Zarxio, in 2015. It has over 10 launched biosimilars in a number of markets and over 20 assets in its pipeline.
16GF Score

Get the complete analysis for MEX:SDZN

Notes Receivable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN1,481.70
Price